Poseida Therapeutics, Inc. earnings per share and revenue

PSTX earnings per share for the last quarter are -0.27 USD whereas the estimation was -0.39 USD which accounts for 30.05% surprise. Company revenue for the same period amounts to 25.00 M USD despite the estimated figure of 6.65 M USD. Estimated earnings per share for the next quarter are -0.42 USD, and revenue is expected to reach 11.67 M USD. Also watch annual changes over time to get a bigger picture of PSTX earnings per share and revenue dynamics.